| Names | |
|---|---|
| Preferred IUPAC name | 3,5,6-Trichloro-2-pyridinol |
| Other names | Clopidolum 3,5-Dichloropyridinol Clozyl Clofolan |
| Pronunciation | /ˈkləʊ.pɪ.dɒl/ |
| Identifiers | |
| CAS Number | 2971-90-6 |
| Beilstein Reference | 3105954 |
| ChEBI | CHEBI:3760 |
| ChEMBL | CHEMBL141838 |
| ChemSpider | 8645 |
| DrugBank | DB11373 |
| ECHA InfoCard | 03d7c8db-c5b6-415b-bc0d-e6e660eb29da |
| EC Number | 202-611-6 |
| Gmelin Reference | 85957 |
| KEGG | C13729 |
| MeSH | D003026 |
| PubChem CID | 2803 |
| RTECS number | GU9100000 |
| UNII | Y7H08Y58WT |
| UN number | 3077 |
| Properties | |
| Chemical formula | C7H7ClN2O |
| Molar mass | 282.573 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 1.42 g/cm³ |
| Solubility in water | Slightly soluble in water |
| log P | 1.99 |
| Vapor pressure | 6.94E-8 mmHg |
| Acidity (pKa) | 6.3 |
| Basicity (pKb) | 6.52 |
| Magnetic susceptibility (χ) | -72.0·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.583 |
| Dipole moment | 3.71 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 326.7 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -101.3 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3313 kJ/mol |
| Pharmacology | |
| ATC code | QG01BX90 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. May cause respiratory irritation. |
| GHS labelling | GHS07, Warning |
| Pictograms | ``` SGH07|SGH09 ``` |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | Keep out of reach of children. Avoid contact with skin, eyes and clothing. Do not breathe dust. Wash thoroughly after handling. Do not contaminate food or feed. |
| NFPA 704 (fire diamond) | 2-1-0 |
| Flash point | 82.7 °C |
| Autoignition temperature | 400°C |
| Lethal dose or concentration | LD₅₀ (oral, rat): 2220 mg/kg |
| LD50 (median dose) | LD50 (median dose): 3740 mg/kg (rat, oral) |
| NIOSH | NIOH: GB9625000 |
| PEL (Permissible) | PEL: Not Established |
| REL (Recommended) | 20 – 60 mg/kg |
| IDLH (Immediate danger) | Not established |
| Product Identification | Technical Commentary |
|---|---|
|
Product Name: Clopidol IUPAC Name: 3,5-dichloro-2,6-dimethyl-4-pyridinol Chemical Formula: C7H6Cl2NO Synonyms & Trade Names: 3,5-Dichloro-2,6-dimethyl-4-pyridinol, Cloxidol HS Code & Customs Classification: 2933.39 |
Industrial Production ObservationsClopidol manufacturing draws strict boundaries on raw material grade, given pyridine ring chemistry's sensitivity to trace contaminants. Side reactions commonly arise from halogenated intermediates. Attention to the purity of dichloroacetyl and methyl starting materials directly influences product profile and downstream removal of residuals. Selection of synthesis route, whether direct chlorination or staged substitution, impacts impurity matrix and cost control in plant operation. Grade-Dependent PropertiesCommercial Clopidol supplies come in several grades intended for feed additive, research, or downstream pharmaceutical intermediate use. The required residual solvent thresholds, heavy metal cutoffs, and isomeric purity align with the application domain or geographical regulatory requirement. Quality Control, Release, and Batch ConsistencyRoutine quality assurance for Clopidol includes batch endpoint determination via HPLC and GC for volatile organic impurities, confirmation of chlorine incorporation, and moisture by Karl Fischer titration. Batch-to-batch consistency stabilizes by tightening process timeline and temperature windows during halogenation and by continuous removal of acidic byproducts. Strict release occurs only when the cumulative impurity envelope sits within customer or national standards. Handling, Storage, and Formulation ConsiderationsPacking and storage protocols change based on the sensitivity of the Clopidol batch to hydrolysis and light exposure. Bulk process lots often call for lined drums or nitrogen blanket to reduce oxidative degradation. Downstream premix formulation requires in-plant compatibility and non-reactivity checks with carriers or diluents, especially when manufacturing feed-grade premix products. HS Code and Trade ComplianceThe assigned HS Code 2933.39 follows international commodity classification for pyridine derivatives and governs customs duties and import documentation. Manufacturer-origin paperwork must align the specification sheet to the relevant customs chapter to prevent shipment delays or reclassification risk at the border. |
In production, Clopidol generally appears as a solid crystalline powder with coloration ranging from off-white to pale yellow depending on purification levels and starting material quality. Odor is minimal and often only detectable during certain extraction steps. Actual melting, boiling, and flash points shift based on grade, moisture content, and physical handling. These values will differ for technical versus feed-grade versions.
Bulk density and tap density in manufacturing lots are strongly influenced by crystal morphology and residual fines from milling. Solubility shifts with particle size, temperature, pH, and solvent choice. Water solubility remains quite limited; process engineers usually suspend Clopidol for blending rather than attempt complete dissolution. For analytical preparation, organic solvents are commonly used, with selection based on downstream use and regulatory restrictions in regional markets.
Technical stability is dictated by residual solvents, trace oxidants, and particle surface area. In-process batches show higher sensitivity to heat and light prior to purification. Finished material stored in proper conditions holds well, but exposure to high humidity can accelerate surface degradation or caking, especially if anti-caking agents are not included.
Chemical specification and impurity maxima are always grade- and customer-specific. For feed additives, maximum allowable impurity levels and assay requirements are stricter than for industrial intermediates. Presentation form—powder, granule, or premix—may result in different standard moisture and bulk flow targets.
Impurity sources trace to both raw materials and process controls: unreacted chlorinated intermediates, solvent residues, or side products from ring chlorination. Control thresholds for these are adapted to market needs and local regulatory requirements. Final specification release is tied to in-house analytical profiles aligned to agreed customer contracts.
Quality control labs apply HPLC, GC, and NMR methods tailored per finished grade. Feed-grade Clopidol typically follows region-specific or Codex-linked standards for active content and impurity cutoffs, but final approval depends on method validation against individual customer requests.
Raw materials sourcing focuses on chlorinated phenols, piperidine, and chlorinating agents, with batch traceability built into our procurement process. Consistency in color and particle size of inputs directly impacts overall purity and minimal impurity drift.
Most industrial facilities adopt a ring chlorination-coupling mechanism. Process optimization hinges on catalyst efficiency and recovery, minimized side chlorination, and efficient use of solvents to enable repeatable conversion rates. Each batch is adjusted for slight input variability.
Key controls include reaction temperature, catalyst dose, and phase separation efficiency. Side product removal rests on precipitation, solvent extraction, and careful neutralization. Impurity drag-through is most common during solvent recovery; thus, purification steps include active carbon treatment or reprecipitation depending on impurity load and final grade demand.
Before release, samples are screened for residual solvent, trace heavy metals, particle size, moisture, and aggregate impurity load. Only batches meeting full internal standards for target grade proceed for bagging and shipment. Batch-to-batch reproducibility remains a critical audit point for domestic and foreign customers alike.
Clopidol’s core ring structure resists most mild nucleophiles but will respond to more aggressive base- or acid-promoted modification depending on process needs. Selective hydrogenation or halogen exchange can generate derivatives, but reaction control demands close monitoring to avoid partial dechlorination or ring cleavage.
Reaction temperatures are tightly controlled to limit over-chlorination and reduce byproduct formation. Solvents are chosen for compatibility with downstream feed regulations or disposal limits, and catalyst residue must remain within trace thresholds to meet food and feed requirements.
With suitable process design, ring substitution or side-chain variation allows for the creation of custom coccidiostat molecules. Some customers seek tailored intermediates for integration into more complex veterinary pharmaceuticals; process route modifications are matched to those downstream requirements.
Clopidol grades for commercial use demand low-humidity, low-light environments. Direct exposure to sunlight or high atmospheric moisture can alter appearance and cause slow active degradation. Inert atmospheres rarely see use except in specific high-purity inventories.
Storage vessels are selected for physical and chemical compatibility—high-density polyethylene and lined fiber drums are commonly used, as Clopidol reacts with some metals if conditions allow moisture ingress. Feed-grade product for export gets additional internal packaging to minimize transit degradation.
Shelf life is primarily affected by storage temperature and humidity, with product caking, color shift, or development of mild off-odor serving as signals for degradation. These indicators prompt full retest before intended use.
Hazard classification for Clopidol falls under moderately hazardous compounds—GHS category and applied statements depend on national regulation of veterinary pharmaceuticals. Manufacturer data sheets always reflect local requirements for hazard notification, protective equipment, and disposal.
Toxicity values for active ingredient and identified impurities vary by batch grade and national feed acceptance. In-house evaluations and regulatory reports guide worker safety measures. Respiratory protection and skin contact avoidance remain standard. Engineering controls at transfer and packaging limit dust exposure, especially in bulk handling. All waste and slurries are managed through dedicated effluent streams. Final safety recommendations depend on customer end-use and jurisdictional product registration.
Clopidol production relies on process route selection, precursor availability, and batch scheduling flexibility. Production capacities vary seasonally and are contingent on allocation of reactors and auxiliary systems. Prioritization for pharmaceutical, veterinary, and feed-grade markets requires advance production planning, as dedicated lines are standard for different impurity profiles. Plant loads are adjusted quarterly based on both forecast and confirmed orders, with batch-processing enabling adaptability but also imposing practical ceilings on peak output. Deviations in raw material supply, utility interruption, or regulatory hold can tighten capacity and should be factored into order timelines.
Production lead times for clopidol shipment adhere to allocated weekly manufacturing windows and solvent recovery cycles. Order-specific grades, special packaging, and custom documentation can extend fulfillment period, with average lead time affected most by QA/QC release and complex customer audits. MOQ commitments reflect line cleaning requirements, especially when alternating between different grades or APIs—smaller batches are generally feasible for R&D or specialty grades but not all sites are equipped for micro-batch production.
Packaging configurations link to safety data, moisture sensitivity, and transit integrity. Most bulk feed-grade volumes ship in fiber drums or multi-layer PE-lined bags on pallets. Higher-purity pharmaceutical grades typically require inner HDPE liner, aluminum foil wrap, and tamper-evident closure. Export shipments adapt to destination-specific handling standards; custom packaging for hazardous transit or temperature-controlled logistics must pass in-house validation.
Shipping terms are generally EXW, FOB main port, or CIF depending on regional logistics partner capabilities and import permit cycles. Certifications for each lot, e.g., CoA, TSE/BSE, or DMF support, must pass both internal and customer review pre-dispatch. Payment terms depend on credit history and region; L/C preferred for first-time partners, open account only for established customers with prior performance. Key global transshipment hubs impact route planning based on seasonal congestion and regulatory inspections.
Clopidol synthesis cost drivers trace to core intermediates, with halogenated aromatics and specialty reagents exhibiting volatility due to upstream supply chain changes. Direct material costs recurrently see pressure during periods of petrochemical feedstock variation or when specialty intermediates encounter tariff or regulatory shifts. Inorganic base and solvent recovery costs contribute to unit economics and scale differently for feed and pharma grades. Margin stability depends on effective solvent recycle ratios and local utility pricing—electricity and steam rates are non-trivial contributors in the overall cost base.
Price ladders directly track industrial, feed, and pharma grades, reflecting incremental process controls, dedicated assets, and enhanced impurity management requirements. Pharmacopeia-conforming clopidol commands a tiered premium, reflecting analytical testing burdens and more stringent batch segregation. Packaging and statutory documentation further differentiate output by destination or segment. Formal audit, customer on-site release, and tailored batch records for regulated markets add significant handling and compliance overhead to the offer structure.
Clopidol raw material price movement typically follows trends in energy, labor, industrial solvent, and specialty precursor markets. Market tightness for key chlorine and pyridine derivatives can drive cost increases rapidly, especially when export quotas or environmental shutdowns hit the region. Trade policy change, force majeure from major upstream producers, and plant-level incidents (fires, maintenance) ripple through the supply timeline, swiftly impacting bargaining power on essential reactants.
Core pricing levers relate to grade (feed, technical, pharma), batch purity, and packaging traceability. Higher-purity lots necessitate longer purification cycles, stricter QA parameters, and operator time for release documentation. Regulatory certification—especially for export to US, EU, or JP—introduces additional stability/batch compliance checks and incurs recurring cost per lot. Custom packaging and destination-mandated labeling create pass-through cost differentials by shipment and should be anticipated in rate requests.
Global clopidol demand traces to livestock health, anticoccidial agent applications, and veterinary medicine, with Asia Pacific and North America ranking as major offtakers. Recent years show tighter integration among large manufacturers, limiting spot market volumes and favoring annual offtake arrangements. Emerging regulatory scrutiny in animal nutrition and evolving resistance profiles in end-use markets affect medium-term consumption forecasts.
US and EU enforce rigorous import requirements, demanding audit trails and full batch-level GMP compliance for pharma and feed sectors. Producers maintain dedicated export lines, with release criteria tied to both product purity and track record of regulatory adherence. China and India operate as the largest global producers, competitively supplying feed and technical grades on a just-in-time or quarterly contract system. Japanese customers require higher traceability and long-term packaging stability, often favoring partners providing extended analytical profiling.
Anticipated supply and demand dynamics suggest sustained upward pressure on clopidol pricing through 2026, particularly in pharma and export-grade categories. Key influences: global tightening in halogenated precursor supply, ongoing upgrades in plant emission controls, and stricter regulatory inspections. Significant swings in utility and labor rates, plus logistics disruption risk, remain baseline price pressures. End-user transitions to alternative actives in developed markets may counterbalance these trends but have not materially shifted aggregate demand as of Q2 2024. Ongoing trade policy shifts, especially in the Pacific Rim region, will set the dominant market tone.
Forecasts and analysis are based on internal production data, supply agreements, and published regional trade flows, cross-referenced against major regulatory alerts and industry association bulletins. Tier-1 feed and pharma purchasers corroborate demand signals through multi-year contract review. Data interpretation follows manufacturer accounting standards and reconciles with monthly batch output reports.
Market attention currently focuses on implementation timelines for newly adopted environmental discharge controls in upstream chemical parks, which have temporarily disrupted routine clopidol intermediate production. Shifts in feed additive registration requirements in several Southeast Asian and South American jurisdictions have led to an uptick in last-minute demand and expedited shipment requests for certified lots.
Recent regulatory updates, especially in the EU and US, necessitate enhancements in impurity profiling, batch-by-batch retesting, and expanded retention sample archiving. Certification renewals require additional documentation, with authorities seeking clearer linkage to upstream batch genealogy and raw material source declarations. Updates were implemented in internal systems within the past 12 months, with batch-specific traceability controls upgraded to align with inspection feedback.
Manufacturers adjusted production windows and implemented dual-sourcing strategies for core halogenated intermediates following recent volatility. QA and regulatory teams rolled out updated audit trails and electronic release documentation to speed up throughput for export-grade batches. Enhanced staff training and real-time process monitoring reduced deviation rates and shortened release cycles in response to new compliance benchmarks.
Clopidol has maintained presence primarily as a coccidiostat for poultry feed. The handling and preparation of Clopidol grades in animal feed integrate quality oversight at each stage—from chemical synthesis, to blending, to bulk or premixed incorporation. Beyond animal nutrition, some regions review Clopidol for research purposes in controlled environments. Entry into non-feed sectors remains strictly regulated and limited by safety and residue scrutiny.
| Grade | Main Application | Key Parameters Influencing Use |
|---|---|---|
| Feed Grade | Poultry feed additive (coccidiostat) | Purity profile, regulatory compliance, physical form (powder, granules), particle size distribution, carrier compatibility |
| Analytical Grade | Veterinary laboratory analysis, R&D | Trace impurity level, batch traceability, documentation package |
For feed-grade Clopidol, main factors affecting suitability include compliance with regional veterinary drug standards, residue control requirements, and physical characteristics impacting mixture homogeneity in feed mills. Lot-to-lot behavior, moisture sensitivity, and residual solvent profile can all influence ease of use and downstream safety validation. The analytical grade primarily impacts method development and accuracy of trace-level detection in feed matrices or biological tissue.
Set the intended use: commercial feed production demands different performance and compliance compared to use in a research environment or laboratory protocol validation.
National veterinary regulations, maximum residue limits, and accepted excipient lists all influence both the targeted grade and the specific analytical parameters required on the certificate of analysis. Each region may specify unique release criteria, such as impurity thresholds, residual solvent limits, and residue depletion intervals.
Feed-grade typically specifies a minimum acceptable purity while tolerating trace levels of related substances and process impurities. Veterinary and research applications generally require narrower purity ranges and more detailed impurity mapping, both to meet method sensitivity and to enable robust validation.
Large feed mills may require multi-ton volumes with repeatable release parameters batch-to-batch. Small R&D labs may focus on limited-use packs with exhaustive documentation. Industrial buyers must weigh cost-effectiveness against the cost of rework or batch rejection if a critical parameter falls outside of specification.
Early batch samples, along with technical support on formulation compatibility, granulation, and homogeneity performance, will clarify final suitability better than published specification sheets alone. Manufacturer support teams can arrange validation trials using in-house or customer-specified test conditions.
Raw materials are sourced with traceability and supply chain integrity as priority. Analytical confirmation and impurity screening follow procurement. Feed-grade routes emphasize cost efficiency and safe handling, while grades intended for analytical reference may require additional purification.
In-process controls emphasize detection of unreacted intermediates, solvent residue, and chemical byproducts. Process adjustments center on impurity reduction without excess energy or resource consumption. Final release standards depend on target application and may include control of particle size, water content, and heavy metals as requested by downstream standards.
To secure release, each batch receives full spectrum analytical checks aligned with customer specification or market regulation. Observed variability tends to relate most to purity, residual organics, and moisture behavior. Storage and transport conditions derive from the moisture and physical stability profile, especially for bulk feed applications exposed to variable humidity.
Quality assurance in Clopidol production builds on a foundation of robust management systems at the plant level. We developed internal traceability and documentation workflows based on international management system standards, such as ISO 9001, and periodically undergo independent site audits to verify system effectiveness. Every step—from raw material vetting to finished lot storage—links back to the documented batch and deviation records. Inspection and test procedures remain locked by both supervisory signatures and data management protocols. Quality consistency gets routinely assessed against control charts, and corrective actions are logged for every non-conformity notice. For audit requests, site documentation or system certification summaries are available upon formal inquiry.
Regulatory requirements for Clopidol change across jurisdictions and application segments. Our technical, registration, and production teams collectively maintain up-to-date dossiers for grades intended for feed additives and industrial intermediates. The compliance with application-driven certifications—such as feed additive registrations or GMP-certified pathways—relies on explicit customer requests and regionally accepted criteria. Ongoing communication with regulatory authorities ensures that customer orders intended for sensitive uses can be manufactured under enhanced documentation and inspection regimes, if required. Standard release protocols are based on lot-specific analytical and impurity profiles matched with the intent of use.
Customers receive product documentation packages tailored to their purchasing specification. For industrial or feed grades, packages typically cover certificate of analysis, manufacturing lot traceability, and route-specific impurity summaries. For enhanced regulatory support, technical dossiers or detailed manufacturing disclosures can be compiled, subject to mutual confidentiality agreement and legal frameworks. Standard practice includes full document retention for the defined shelf life of Clopidol lots, with access available for audit or recall requests. Batch-to-batch variation gets tracked using historical lot data to provide comparative assessments if required.
Manufacturing facilities for Clopidol maintain production lines designed for scalable output. Production schedule adaptability is governed by forecast-sharing and annual planning with key customers. For products requiring grade adjustments or changeover, line scheduling buffers and strict cleaning protocols manage cross-contamination risk and turnaround time. Flexible procurement terms stem from direct collaboration on contract duration, consignment arrangements, and batch size negotiation. For long-cycle tenders or bulk campaigns, reserved capacity blocks are available upon advanced purchase commitment. Logistics teams coordinate with strategic forwarders for tailored delivery windows or contingency warehousing when required by projects prone to batch release lags.
The selection of raw materials sources for Clopidol prioritizes supply chain redundancy and local supplier integration to minimize upstream risk. Production teams operate multiple synthesis loops and maintain critical spares for equipment uptime. In-process controls monitor synthesis, isolation, and drying to manage yield and consistency. Lots remain under quarantine status until final QA signoff based on the customer specification and internal release criteria. The production planning department matches batch frequency to active order volume, ensuring sustained supply for recurring business without overextending storage capacity. The approach to risk mitigation includes robust supplier qualification and dual-source verification to absorb global supply volatility without interrupting delivery promises.
Sample requests for Clopidol start with a technical dialogue to clarify end-use, target application, and requirement for product grade or documentation. Samples can be conditioned in laboratory-scale or pilot lots, depending on the downstream evaluation scale. The technical support team tracks sample origin, lot record, and documentation status for repeatability. Typical lead time for sample preparation depends on production campaign schedule and testing requirements. Feedback loops with customer technical or formulation teams accelerate application troubleshooting, and the dedicated interface streamlines transition from sampling to commercial order.
We operate with multiple cooperation models, responding to customer volume stability, regional logistics complexity, and regulatory requirements. Business modes include annual framework agreements with rolling call-offs, fixed-lot spot purchasing, and on-demand production for specialty grades. Downstream partners receive periodic supply forecasts, scheduled delivery adjustments, and options for joint technical reviews. For emerging markets or clients piloting new formulations, trial orders may receive prioritized line scheduling and reduced lot size minimums. Commercial teams integrate feedback from both technical and operational partners to adjust pricing mechanisms, delivery frequency, or contract terms—ensuring that each model reflects real-world operational risks, customer forecast variability, and the lead times intrinsic to Clopidol manufacture. All cooperation modes are anchored by clear escalation paths for issue resolution and transparent performance metrics shared by both parties.
In Clopidol manufacturing, ongoing research currently prioritizes impurity profile control and optimization of synthesis steps. Upstream raw material selection remains under scrutiny for consistency and sustainability, especially as demand shifts toward alternatives that minimize hazardous byproducts. Technicians working with Clopidol frequently analyze side-reaction suppression and aim for tighter impurity specifications, as different animal health markets are sensitive to variations in feed additive profiles.
Development teams monitor evolving regulations on coccidiostats and seek to anticipate shifts toward new animal species or novel delivery matrixes. Product customization requests increasingly originate from premix processors and integrators, who look for enhanced compatibility with complex feed formulations. There is technical activity around water-soluble Clopidol and multi-component blends, particularly where integration with next-generation growth promotants occurs.
Batch-to-batch consistency and formulation robustness often require advanced in-process controls. Technical groups focus efforts on minimizing carryover of structurally related impurities, especially during continuous versus batch synthesis. Recent breakthroughs include improved catalyst selection and closed-process designs that reduce operator exposure and environmental release risks. Process analytical technology gets adopted for real-time monitoring of critical intermediates, limiting the risk of off-grade batches.
Volume trends for Clopidol track closely with shifts in global poultry and specialty livestock output. Demand fluctuations generally align with region-specific regulatory changes and cycles in protein consumption. Supply-demand balance changes quickly if feed additive regulations in export markets are revised. Production planners anticipate periodic revalidation for residue criteria in end products, depending on country-specific maximum residue limit updates.
Process routes are in transition toward solvent use minimization and integrated waste valorization. Equipment retrofits target higher throughput and energy efficiency, contributing to lower carbon footprints. Industrial producers are investigating automated inline impurity detection for greater batch release confidence. Advances in purification may further enable special grades tailored for emerging animal classes or medicated feed substrates.
Raw material choices increasingly favor renewable feedstocks where supply chain reliability is proven. Manufacturing groups evaluate the lifecycle of auxiliary materials and shift away from those creating persistent or toxic residues. Efforts focus on waste reduction, closed-loop solvent handling, and effluent treatment. Green chemistry principles push pilot projects in catalyst recyclability and reduced energy input per ton of finished Clopidol.
Customers often require clarification on compatibility with premix ingredients, downstream process adjustments, and strategies to minimize degradation under variable field conditions. Technical teams provide detailed impurity data, batch history, and stability guidance aligned to the grade and intended geographic market. Support includes advice on blending sequences, equipment cleaning practices, and analytical troubleshooting.
Formulation specialists assist in scaling solutions to laboratory, pilot, and commercial scale, always considering grade-specific flowability, dispersibility, and reactivity requirements. The company supports adjustment of premix ratios during transitions between batches or process improvements in finished feed. Where regulatory limits or application compatibility shift, updated technical files and validation samples are provided based on actual batch data.
The manufacturer's quality system traces each batch from raw material intake through release, allowing product recall or investigation as required by market. Replacement policy and technical remediation processes are structured around traceable lot codes and direct access to support chemists. Documented root cause investigation protocols ensure that any deviation from customer specification or field performance triggers corrective action and follow-up.
Producing clopidol at industrial scale requires rigorous control of inputs and tight management of every processing step. Across the industry, poultry premix formulators and integrators depend on stable, repeatable quality for effective coccidiosis prevention. At our facility, we handle clopidol production from the initial synthetic process to final packaging. This approach gives us direct leverage over specification compliance, batch reproducibility, and reliable supply.
Clopidol synthesis involves a sequence of chemical transformations, each stage controlled by strict process parameters. Monitoring temperature, reaction time, and raw material purity ensures optimal conversion rates and minimizes by-product formation. Our in-house laboratory validates every lot through advanced chromatographic assays, confirming active ingredient strength and tightly managed impurity profiles. We never rely on outsourced blending or toll manufacturing, so customers receive product that matches precisely defined technical standards without deviation from order to order.
Poultry feed manufacturers, veterinary premix producers, and integrated farming companies account for most clopidol demand. The compound serves as a backbone for medicated feed additives designed to protect broilers from coccidiosis during early growth cycles. Integrators and commercial feed mills seek predictable product performance across feed batches and production cycles. Achieving this outcome comes down to uniform physical properties and steady chemical consistency, which depend on tight control of synthesis parameters and in-house finishing procedures. End users count on reproducible fine powder characteristics for precise dosing and minimal segregation during blending.
Industrial buyers often require adjustments in order size and packaging type tailored to their production environment. We supply clopidol in bulk fiber drums with polyethylene liners, as well as smaller packed formats for centralized premix operations. Each drum receives sequential lot coding for full traceability through shipment and inventory management. Our logistics teams schedule containers and inland freight in line with plant loading cycles so customers keep line downtime to a minimum. With established export experience, we navigate documentation for global markets and meet specific regulatory and customs requirements as product leaves our facility.
Direct communication between formulators and technical staff speeds problem-solving. Our chemists and feed specialists handle queries around product blending, carrier selection, and process compatibility. By engaging early on technical integration, we help clients optimize product inclusion rates and resolve compatibility issues with existing feed systems. Any observed deviations or requests for custom solution support route to lab and production staff with authority to implement process adjustments.
Feed manufacturers, contract premixers, and procurement specialists see measurable business value by working with a single-source producer. Stable quality reduces the burden of additional incoming QC testing, fewer production stoppages occur due to off-spec raw materials, and quality documentation supports regulatory inspection needs. Our integrated approach supports reliable forward planning for customers facing cyclical demand and evolving regulatory standards. By owning every process from chemical synthesis to drum loading, we remove points of failure and keep large-volume buyers supplied according to their production priorities.
Drawing from decades of direct experience in chemical synthesis and feed additive manufacturing, we see the role of Clopidol as a unique anticoccidial in poultry production. Our chemists observe that Clopidol acts primarily at the early stages of the Eimeria life cycle by interfering with the development of the sporozoite and trophozoite stages inside the bird’s intestinal cells. This targeted timing sets Clopidol apart from ionophores and sulfonamides. The structural properties of our production batch ensure consistent bioavailability and activity throughout feed processing. By blocking parasite development early, Clopidol supports gut integrity and helps maintain steady weight gain, key factors for commercial poultry operators.
Producing Clopidol in-house gives our technical team deep insight into proper dosage ranges. For broilers, we recommend inclusion levels based on practical field feedback and established regulatory limits. Standard dosage often ranges between 100 and 125 mg of active ingredient per kilogram of finished feed. These figures reflect both laboratory study and hands-on customer feedback from intensive farming operations. Exceeding recommended concentrations brings no added benefit but may complicate withdrawal scheduling. Careful batching and mixing practices during production guarantee reliable dose delivery and compatibility with feed mill process controls.
Consistent application means more than picking a number out of a formulary. On our manufacturing floor, our engineers validate every batch for particle size, solubility, and blend behavior to avoid segregation or loss during mixing. Our quality assurance teams test homogeneity in final feed mash. End users report the importance of following withdrawal periods before slaughter to meet residue guidelines. Our research and customer field data show that rotating Clopidol with other anticoccidials reduces the risk of resistance development—a key operational principle for integrated producers working at scale.
Integrators and feed millers regularly seek advice from our technical support staff regarding clean-out flushes, pellet process temperatures, and storage conditions for our Clopidol formulations. We support our customers with updated documentation on regulatory compliance and best use. Manufacturing directly from raw materials, we maintain batch traceability and adapt to shifts in raw material supply, avoiding bottlenecks and quality compromise.
Years of field usage confirm that coccidiosis remains one of the leading health challenges in intensive poultry systems. Our mission is to provide reliable Clopidol as a tool for controlling this disease without undermining flock health or meat product safety. By balancing field trial data with continuous production improvements, we reinforce our reputation as a steady technical partner—giving producers the confidence to maintain performance and meet meat quality targets.
For precise usage in specialist operations, our technical team can provide detailed product data sheets and custom support, ensuring that each flock receives effective protection with minimal disruption. Our ongoing focus remains on reliability, transparency in manufacturing, and traceable supply from plant to farm.
Buying Clopidol directly from our production lines means you work with a company that sees the factory floor every day and understands the real-world logistics behind chemical supply. Clopidol plays a central role in animal feed additives, which introduces unique expectations for packaging, consistency, and shipment integrity. To meet demand from feed producers and premix operators around the globe, we focus on practical packaging options and straightforward minimum order policies that keep logistics simple and cost-effective.
Bulk ordering brings efficiency to both the end-user and to us as a manufacturer. Over decades of manufacturing Clopidol, we have refined our packaging solutions to support ease of handling, protection from the elements, and compliance during transit. Our most common pack size is the 25 kg fiber drum with an inner polythene liner, a staple in the industry for both protection and convenience. This format protects against moisture ingress during storage and transportation, reducing contamination risk and waste. Smaller consumer-sized packaging does not match the technical or operational requirements of our direct clients, so we concentrate on solutions that meet the needs of large-scale commercial operations.
Some buyers require larger unit sizes to reduce handling and transfer times. On request, our team supports alternative packaging such as 500 kg or 1000 kg jumbo bags, provided your facilities are equipped for safe access, movement, and discharge of these larger units. For global bulk supply, we have decades-long experience loading full-container orders with either drums or large bags, ensuring secure sealing and effective palletization. Each batch is accompanied by our in-house documentation and labeling in line with regulatory and transport standards.
It takes substantial planning to run chemical production lines at industrial scale. Small-quantity packing does not suit our factory’s logistics or operational costs, and shipping inefficient lots would increase risk and cost for all parties involved. Our minimum order quantity standard holds at 500 kg net. This volume covers most continuous production schedules for mid-sized feed manufacturers and significantly streamlines shipment arrangements, especially for export. For clients operating larger plants or distribution hubs, full-container load quantities remain the most economical route; not only do direct routes from our plant to your door offer financial savings, they also shield the material from multiple handlings that can introduce hazards or losses.
Buyers should consider both consumption rates and safe inventory turns. With larger lots, you gain flexibility and lower per-ton costs, as well as the benefit of lower risk of product degradation associated with excessive repacking or long-term partial storage. Our technical team can provide detailed handling and storage recommendations tailored to your operational environment upon request. This helps safeguard product quality from our plant through final usage in feed manufacturing.
The feed industry continues to expect reliable, cost-controlled procurement at scale, and as a chemical manufacturer, we align our packing and minimum lot strategies with real-world production cycles on both sides of the transaction. Our order size and packaging policies support consistent supply, predictable pricing, and manageable inventory for your plant. Orders arranged in full-container or palletized bulk allow us to run our operations efficiently, maintain product quality, and pass those efficiencies to our clients.
We have no place for vague promises or outsized marketing claims—our operations stand on the strength of long-term reliability, technical support, and transparency. If your facility has special handling or packaging needs, our engineers are ready to discuss practical solutions grounded in firsthand manufacturing experience. Each shipment reflects our focus on operational discipline and real-world problem-solving, from first drum to last bag.
Our manufacturing teams maintain close cooperation with regional veterinary authorities to ensure our clopidol aligns with current legal frameworks. The rules shaping veterinary medicine remain dynamic, and governments often adjust registration protocols and allowed compounds based on new research or public health priorities. As an active player, we keep our clopidol dossiers up-to-date, reflecting the latest requirements for purity, ingredient traceability, and application scope. We regularly monitor updates issued by regulatory agencies across Asia, Europe, the Americas, and other key markets, actively responding to any changes that could affect the permitted use of clopidol in animal feed applications.
Our process incorporates all relevant residue limit standards for clopidol. We participate in feed additive approval procedures, and our technical documents support transparent regulatory reviews. In markets where clopidol continues receiving positive evaluations, it stays legally approved for coccidiostat use in poultry and some other livestock, provided that the finished feed meets established maximum residue levels (MRLs). If a region restricts clopidol, we take immediate action, revising labelling and post-market monitoring to guarantee compliance. End users and feed producers benefit from our vigilance in upholding these obligations.
Delivering clopidol in prime condition starts on our production line. We package the product in moisture-resistant, sealed bags or drums, shielded from exposure to air, humidity, and direct sunlight. Throughout warehouse storage and shipping, we maintain temperature and humidity parameters that keep the product physically stable and prevent clumping or degradation.
During transport, our focus shifts to eliminating risks of contamination and accidental exposure. Clopidol has a moderate dusting tendency, so all containers remain securely closed through loading, transit, and unloading. We use clean, dedicated trucks or containers, avoiding shared loads with odorous, corrosive, or incompatible materials. Our logistics crew inspects shipments for punctures or leaks before departure and after arrival.
Clopidol does not require refrigeration, but our guidelines specify a dry, ventilated environment during shipment and storage. If ambient temperatures rise significantly, we avoid stacking pallets too tightly, allowing air circulation and reducing unwanted heat buildup. Strict recordkeeping ensures traceability for every batch, from our plant floor through to final delivery at the feed manufacturer’s facility.
Veterinary oversight grows more vigilant each year. Feed industry partners look to us for evidence-based documentation supporting legal compliance. We prepare registration packs with batch analysis reports, production records, and full material safety information. In countries tightening their regulations, we engage in dialogue with regulatory bodies, working to clarify details on permitted uses, withdrawal intervals, and risk management controls.
Based on real-world experience, the key to smooth logistics centers on clear labelling, routine in-process inspections, and timely communication with transport providers. Delays or mishaps pose greater risk when local authorities step up random checks; rapid, transparent documentation helps prevent unnecessary hold-ups. Our technical teams remain on call to help users interpret local regulations and make informed decisions on proper storage, handling, and feed formulation.
We continue investing in manufacturing quality systems and staff training. Our teams stay current on evolving international guidelines, so customers relying on our clopidol receive both a consistent product and documentation reflecting the latest legal mandates. We ensure our network gets early warnings on regulatory shifts affecting clopidol, so partners can keep their own processes compliant and forward-looking.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales7@bouling-chem.com, +8615371019725 or WhatsApp: +8615371019725
